company has reiterated not wanting to commercialise the drugs.
so. phase 1 for PSK9i is starting end of this year into first half 2022.
if things continue to go well and prelim data holds even party.
this will be bought out this time next year.
how they carve out the chol drug from the tbi drug is a good problem to have.
I see this as a 12mo play for multibagger.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $244.1K | 667.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4705 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 597241 | 3 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |